N-PEP-12 - A novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions

Journal of Neural Transmission

Volumn 112, Issue 10, 2005, Pages 1331-1343

  Windisch, M ^a   Hutter Paier, B ^a   Grygar, E ^a   Doppler, E ^b   Moessler, H ^b  

^a JSW Life Sciences GmbH   (Austria)

^b Research Initiative Ebewe   (Austria)

Author keywords

Brain lesion; Growth factors; Neuroprotection; Peptides

Indexed keywords

AMINO ACID; CALCIUM; COLCHICINE; GLUTAMIC ACID; IODOACETIC ACID; IONOMYCIN; N PEP 12; NEUROPEPTIDE; SODIUM CYANIDE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; CHICKEN; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; EMBRYO; EXCITOTOXICITY; HYPOXIA; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STIMULATION; STROKE;

AMINO ACIDS; ANIMALS; BRAIN DISEASES; CELL AGING; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHICK EMBRYO; CHICKENS; COLCHICINE; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUTAMIC ACID; IODOACETATES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; SODIUM CYANIDE;

EID: 25144465426     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0283-7     Document Type: Article

References (80)

1. E Adamec M Mercken ML Beermann M Didier RA Nixon 1997 Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res 757 93 101
2. F Akai S Hiruma T Sato N Iwamoto M Fujimoto M Ioku S Hashimoto 1992 Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol 7 213 221
3. C Arias T Montiel R Quiroz-Báez L Massieu 2002 β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. Exp Neurol 176 163 174
4. M Arundine M Tymianski 2003 Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34 325 337
5. JS Bains CA Shaw 1997 Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res 25 335 358
6. A Baskys MJ Wojtowicz 1994 Effects of brain tissue hydrolysate on synaptic transmission in the hippocampus. Pharmacol Biochem Behav 49 1105 1197
7. JP Blass 2003 Cerebrometabolic abnormalities in Alzheimer's disease. Neurol Res 25 556 566
8. RJ Boado D Wu M Windisch 1999 In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides. Neurosci Res 34 217 224
9. E Braak K Griffing K Arai J Bohl H Bratzke H Braak 1999 Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psy Clin N 249 14 22
10. GJ Brewer 1999 Regeneration and proliferation of embryonic and adult rat hippocampal neurons in culture. Exp Neurol 159 237 247
11. SR Bruckner G Perry S Estus 2003 4-hydroxynonenal contributes to NGF withdrawal-induced neuronal apoptosis. J Neurochem 85 999 1005
12. M Brzyska D Elbaum 2003 Dysregulation of calcium in Alzheimer's disease. Acta Neurobiol Exp 63 171 183
13. JK Callaway 2001 Investigation of AM-36: a novel neuroprotective agent. Clin Exp Pharmacol P 28 913 918
14. 2+ fluxes and neurotoxicity in rat cerebellar granule cells. Brain Res 779 194 204
15. CC Chao EH Lee 1999 Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation. Neuropharmacology 38 913 916
16. MB Collatz R Rudel H Brinkmeier 1997 Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses. Cell Calcium 21 453 459
17. M Cookson C Mead S Austwick V Pentreath 1995 Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures. Toxicol in Vitro 9/1 39 48
18. AK Demetriades 2002 Functional neuroimaging in Alzheimer's type dementia. J Neurol Sci 203 247 251
19. VW Dimlich M Nielsen 1992 Facilitating postischemic reduction of cerebral lactate in rats. Stroke 23/8 1145 1152
20. MF Dubois R Hébert 2001 The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology 20 179 187
21. J Emerit A Edeas F Bricaire 2004 Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58 39 46
22. E Farkas PGM Luiten 2001 Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64 575 611
23. T Fath J Eidenmüller R Brandt 2002 Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22 9733 9741
24. RA Floyd K Hensley 2002 Oxidative stress in brain aging - implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23 795 807
25. F François MJ Godinho M Dragunow ML Grimes 2001 A population of PC12 cells that is initiating apoptosis can be rescued by nerve growth factor. Mol Cell Neurosci 18 347 362
26. Y Gilgun-Sherki Z Rosenbaum E Melamed D Offen 2002 Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54 271 284
27. DE Goll VF Thompson HQ Li W Wei JY Cong 2003 The calpain system. Physiol Rev 83 731 801
28. I Gozes DE Brenneman 2000 A new concept in the pharmacology of neuroprotection. J Mol Neurosci 14 61 68
29. ZH Guo MP Mattson 2000 Neurotrophic factors protect cortical synaptic terminals against amyloid- and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cereb Cortex 10 50 57
30. M Hartbauer B Hutter-Paier G Skofitsch M Windisch 2001 Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm 108 459 473
31. D Hicks V Heidinger S Mohand-Said J Sahel H Dreyfus 1998 Growth factors and gangliosides as neuroprotective agents in excitotoxicity acid ischemia. Gen Pharmacol 30 265 273
32. RR Hicks S Numan HS Dhillon MR Prasad KB Seroogy 1997 Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma. Mol Brain Res 48 401 406
33. L Hillered L Ernster B Siesjö 1984 Influence of in vitro lactic acidosis and hypercapnia on respiratory activity of isolated rat brain mitochondria. J Cerebr Blood Flow Met 4 430 437
34. S Hoyer 2003 Memory function and brain glucose metabolism. Pharmacopsychiatry 36 S62 S67
35. B Hutter-Paier E Steiner M Windisch 1998 Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia. J Neural Transm [Suppl] 53 351 361
36. B Hutter-Paier E Grygar M Loibner G Skofitsch M Windisch 2000 Effects of NaCN and ionomycin on neuronal viability and on the abundance of microtubule-associated proteins MAP1, MAP2, and tau in isolated chick cortical neurons. Cell Tissue Res 302 39 47
37. J Jaboin CJ Kim DR Kaplan CJ Thiele 2002 Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 62 6756 6763
38. K Katasura A Ekholm BS Asplund 1991 Extracellular pH in the brain during ischemia: relationship to the severity of lactic acidosis. J Cereb Blood Flow Metab 11 597 599
39. 2+ channel antagonists and neuroprotection from cerebral ischemia. Eur J Pharmacol 363 1 15
40. J Krieglstein 1997 Excitotoxicity and neuroprotection. Eur J Pharm Sci 5 181 187
41. T Kristian BK Siesjo 1998 Calcium in ischemic cell death. Stroke 29 705 718
42. DA Le YQ Wu ZH Huang K Matsushita N Plesnila JC Augustinack BT Hyman JY Yuan K Kuida RA Flavell MA Moskowitz 2002 Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 99 15188 15193
43. EM Mandelkow E Mandelkow 1998 Tau in Alzheimer's disease. Trends Cell Biol 8 425 427
44. WR Markesbery 1999 The role of oxidative stress in Alzheimer disease. Arch Neurol 56 1449 1452
45. L Massieu N Gómez-Román T Montiel 2000 In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp Neurol 165 257 267
46. MP Mattson W Duan WA Pedersen C Culmsee 2001 Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6 69 81
47. PP Michel EC Hirsch Y Agid 2002 Parkinson's disease: cell death mechanisms. Rev Neurol 158 S24 S32
48. SL Minger JW Geddes ML Holtz SD Craddock SW Whiteheart RG Siman LC Pettigrew 1998 Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res 810 181 199
49. T Miyazawa K Matsumoto H Ohmichi H Katoh T Yamashima T Nakamura 1998 Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 18 345 348
50. U Müller J Krieglstein 1995 Inhibitors of lipid peroxidation protect cultured neurons against cyanide-induced injury. Brain Res 678 265 268
51. Y Nakagawa-Yagi DK Choi N Ogane S Shimada M Seya T Momoi T Ito Y Sakaki 2001 Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death. Brain Res 909 8 19
52. JA Park JY Lee TA Sato JY Koh 2000 Co-induction of p75(NTR) and p75(NTR)-associated death executor in neurons after zinc exposure in cortical culture or transient ischemia in the rat. J Neurosci 20 9096 9103
53. HF Poon V Calabrese G Scapagnini DA Butterfield 2004 Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol Ser A Biol Sci Med 59 478 493
54. K Prass U Dirnagl 1998 Glutamate antagonists in therapy of stroke. Restor Neurol Neuros 13 3 10
55. JH Prehn J Krieglstein 1993 Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34 179 188
56. JL Price AI Ko MJ Wade SK Tsou DW McKeel JC Morris 2001 Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58 1395 1402
57. R Raghupathi 2004 Cell death mechanisms following traumatic brain. Brain Pathol 14 215 222
58. K Reinprecht B Hutter-Paier K Crailsheim M Windisch 1998 Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro. J Neural Transm [Suppl] 53 373 384
59. KP Riley DA Snowdon WR Markesbery 2002 Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the nun study. Ann Neurol 51 567 577
60. J Rudolf 2002 Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 14 33 41
61. WR Schabitz S Schwab M Spranger W Hacke 1997 Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cerebr Blood Flow Metab 17 500 506
62. P Scheltens 2001 Structural neuroimaging of Alzheimer's disease and other dementias. Aging Clin Exp Res 13 203 209
63. PT Shah KW Yoon XM Xu LD Broder 1997 Apoptosis mediates cell death following traumatic injury in rat hippocampal neurons. Neuroscience 79 999 1004
64. E Sigalov M Fridkin DE Brenneman I Gozes 2000 VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells. J Mol Neurosc 15 147 154
65. PJLM Strijbos 1998 Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity. Crit Rev Neurobiol 12 223 243
66. CD Sturm WA Frisella K Yoon 1993 Attenuation of potassium cyanide-mediated neuronal cell death by adenosine. J Neurosurg 79 111 115
67. AY Sun JH Cheng 1999 Novel targets for therapeutic intervention against ischemic brain injury. Clin Neuropharmacol 22 164 171
68. DF Swaab 2003 Reactivation of atrophic neurons in Alzheimer's disease. Neurol Res 25 652 660
69. M Torcia G DeChiara L Nencioni S Ammendola D Labardi M Lucibello P Rosini LNJL Marlier P Bonini P DelloSbarba AT Palamara N Zambrano T Russo E Garaci F Cozzolino 2001 Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome C release. J Biol Chem 276 39027 39036
70. MH Tuszynski 2000 Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant 9 629 636
71. JC Vickers TC Dickson PA Adlard HL Saunders CE King G McCormack 2000 The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol 60 139 165
72. JM Vongher CA Frye 1999 Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav 64 777 785
73. NG Wahlgren N Ahmed 2004 Neuroprotection in cerebral ischaemia: facts and fancies - The need for new approaches. Cerebrovasc Dis 17 153 166
74. L Wei SP Yu F Gottron BJ Snider GJ Zipfel DW Choi 2003 Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo. Stroke 34 1281 1286
75. J Weis S Saxena M Evangelopoulos A Kruttgen 2003 Trophic factors in neurodegenerative disorders. Iubmb Life 55 353 357
76. GJ Wells R Bihovsky 1998 Calpain inhibitors as potential treatment for stroke and other neurodegenerative diseases: recent trends and developments. Expert Opin Ther Pat 8 1707 1727
77. L Williams 1995 Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment. Cerebrovasc Brain Met 7 55 73
78. T Yamashima Y Kohda K Tsuchiya T Ueno J Yamashita T Yoshioka E Kominami 1998 Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 10 1723 1733
79. WH Ying 1997 Deleterious network: a testable pathogenetic concept of Alzheimer's disease. Gerontology 43 242 253
80. JA Zivin 1997 Neuroprotective therapies in stroke. Drugs 54 [Suppl 3] 83 89